Tech Company Financing Transactions

Cardeas Pharma Funding Round

Cardeas Pharma, operating out of Seattle, raised $34 million from H.I.G. Capital, Avalon Ventures and De Novo Ventures.

Transaction Overview

Company Name
Cardeas Pharma
Announced On
5/23/2013
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series B
Investors

H.I.G. Capital (Lead Investor) (Aaron Davidson)

Avalon Ventures (Kevin Kinsella)

De Novo Ventures

Devon Park Bioventures

Novo Ventures (Peter Moldt)

WRF Capital (Thong Le)

Proceeds Purpose
Funds from this financing will be used to support Phase 2 development of Cardeas' lead compound, investigational amikacin/fosfomycin inhalation solution delivered via an eFlow InLine Nebulizer system, as a potential treatment for healthcare associated pneumonia (HCAP) in patients on mechanical ventilation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2025 1st Ave. 1200
Seattle, WA 98121
USA
Phone
(206) 973-1026
Website
www.cardeaspharma.com
Email Address
Not Recorded
Overview
Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.
Profile
Cardeas Pharma LinkedIn Company Profile
Social Media
Cardeas Pharma Company Twitter Account
Company News
Cardeas Pharma News
Facebook
Cardeas Pharma on Facebook
YouTube
Cardeas Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bruce Montgomery
  Bruce Montgomery LinkedIn Profile  Bruce Montgomery Twitter Account  Bruce Montgomery News  Bruce Montgomery on Facebook
Chief Operating Officer
Melissa Yeager
  Melissa Yeager LinkedIn Profile  Melissa Yeager Twitter Account  Melissa Yeager News  Melissa Yeager on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/23/2013: Happy Cloud venture capital transaction
Next: 5/23/2013: AlephCloud Systems venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.